<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22568881</article-id>
      <article-id pub-id-type="pmc">3487756</article-id>
      <article-id pub-id-type="publisher-id">1746-1596-7-50</article-id>
      <article-id pub-id-type="doi">10.1186/1746-1596-7-50</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Renal infarction due to polyarteritis nodosa in a patient with angioimmunoblastic T-cell lymphoma: a case report and a brief review of the literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Ambrosio</surname>
            <given-names>Maria Raffaella</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>maradot@libero.it</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Rocca</surname>
            <given-names>Bruno Jim</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>brunojim@libero.it</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Ginori</surname>
            <given-names>Alessandro</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>alessandroginori@unisi.it</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Onorati</surname>
            <given-names>Monica</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>monica.onorati@libero.it</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Fabbri</surname>
            <given-names>Alberto</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>fabbri@unisi.it</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Carmellini</surname>
            <given-names>Mario</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>carmellini@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Lazzi</surname>
            <given-names>Stefano</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>lazzi2@unisi.it</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Tripodi</surname>
            <given-names>Sergio</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>tripodis@unisi.it</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Human Pathology and Oncology, Pathological Anatomy Section, University of Siena, via delle Scotte, Siena, 6 - 53100, Italy</aff>
      <aff id="I2"><label>2</label>Unit of Hematology and Transplant, University of Siena, Siena, Italy</aff>
      <aff id="I3"><label>3</label>Unit&#xE0; Operativa Chirurgia dei Trapianti, Azienda Ospedaliera Universitaria Senese, Senese, Italy</aff>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>5</month>
        <year>2012</year>
      </pub-date>
      <volume>7</volume>
      <fpage>50</fpage>
      <lpage>50</lpage>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>3</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>4</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2012 Ambrosio et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Ambrosio et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.diagnosticpathology.org/content/7/1/50"/>
      <abstract>
        <p>Angioimmunoblastic T-cell lymphoma is one of the most common subtypes of peripheral T-cell lymphoma (15-20% of all cases), accounting for approximately 1-2% of all non-Hodgkin lymphomas. It often presents autoimmune phenomena including hemolytic anemia, thrombocytopenia, glomerulonephrities and circulating immune complexes. Polyarteritis nodosa is an autoimmune disease characterized by necrotizing vasculitis of medium vessels, which rarely develops in association with hematological malignant disorders. Herein we report the case of a 40-year-old man who underwent lymph node biopsy in the suspicious of sarcoidosis. On the basis of histological and immunohistochemical findings, the diagnosis of angioimmunoblastic T-cell lymphoma was performed. The patient was successfully treated with cytarabine-based regimen for 6 cycles. Three months after the initial diagnosis of angioimmunoblastic T-cell lymphoma, a whole body computed tomography showed a lesion in the lower pole of the left kidney. Renal cell carcinoma was suspected, thus a nephrectomy was carried out. The histological findings were compatible with polyarteritis nodosa. To the best of our knowledge, the association between polyarteritis nodosa and angioimmunoblastic T-cell lymphoma has been described only once. This relation may be secondary to the induction of an autoimmune phenomenon by the lymphoma with the formation of circulating immune complexes, leading to vessels walls injury. A careful evaluation is needed in the management of angioimmunoblastic T-cell lymphoma patients with signs of renal failure in order to avoid delay of treatment and organ damage.</p>
      </abstract>
      <kwd-group>
        <kwd>Renal infarction</kwd>
        <kwd>Polyarteritis nodosa</kwd>
        <kwd>T-cell lymphoma</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>The World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues defines the Angioimmunoblastic T-cell lymphoma (AITL) as one of the more common specific subtypes of peripheral T-cell neoplasms, accounting for approximately 15-20% of all cases, or 1-2% of all non-Hodgkin lymphomas [<xref ref-type="bibr" rid="B1">1</xref>]. It occurs in middle age and elderly, with an equal incidence in males and females and has an aggressive clinical behavior, often with fever, skin rash, generalized lymphadenopathy, hepatosplenomegaly and autoimmune phenomena including hemolytic anemia, thrombocytopenia, glomerulonephrities and circulating immune complexes (CIC). Histologically, it is characterized by polymorphous infiltrate involving lymph nodes, and prominent proliferation of high endothelial venules and follicular dendritic cells. During the clinical course of a lymphoma, many lesions (not only direct invasion by neoplastic cells) may affect the kidney as broad phenomenon disorders [<xref ref-type="bibr" rid="B2">2</xref>]. This finding is more common in Hodgkin&#x2019;s disease rather than non-Hodgkin&#x2019;s lymphoma. During the clinical course of AITL, proliferative glomerulonephritis [<xref ref-type="bibr" rid="B3">3</xref>], minimal-change disease [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>], A-type amyloidosis [<xref ref-type="bibr" rid="B2">2</xref>], acute renal failure [<xref ref-type="bibr" rid="B6">6</xref>], immunoglobulin (Ig)M-&#x3BB; glomerular thrombi, and membranoproliferative glomerulonephritis-like lesions [<xref ref-type="bibr" rid="B7">7</xref>], myeloma-like kidney [<xref ref-type="bibr" rid="B8">8</xref>], direct invasion by lymphoma cells [<xref ref-type="bibr" rid="B9">9</xref>], interstitial nephritis [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>], vasculitis [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], nephrocalcinosis [<xref ref-type="bibr" rid="B14">14</xref>], Fanconi syndrome [<xref ref-type="bibr" rid="B15">15</xref>] and nephrotic syndrome due to membranous nephropathy (MN) [<xref ref-type="bibr" rid="B16">16</xref>] may be rarely observed.To the best of our knowledge, there is only one previous case of AITL associated with polyarteritis nodosa (PAN) [<xref ref-type="bibr" rid="B17">17</xref>]. Herein, we report a very unusual complication in AITL, a renal necrotic lesion due to vasculitis with the appearance of PAN, clinically misdiagnosed as renal carcinoma, highlighting the possible pathogenic mechanism.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <sec>
        <title>Clinical summary</title>
        <p>A 40&#x2009;year-old-male patient presented to his general practitioner with a 3-weeks history of myalgia, arthralgia, fever (37.5&#xB0;C) and cough which persisted despite a broad-spectrum antibiotic therapy. For this, he underwent a chest X-ray examination which showed bilateral lung nodules and enlarged mediastinal lymph nodes, with a clinical picture consistent with sarcoidosis. The patient was admitted to the Pneumologic Unit of Siena University Hospital. On admission, physical examination showed generalized lymphadenopathy, splenomegaly and skin rash. The laboratory data are summarized in Table <xref ref-type="table" rid="T1">1</xref>. The blood count, liver and renal function, as well as angiotensin converting enzyme (ACE), were within the reference range. Eosinophilia and hypergammaglobulinemia were not found whereas C-reactive protein, lactate dehydrogenase, &#x3B2;2-microglobulin and serum immunoglobulins were increased. Since the clinical picture was doubtful, the patient underwent biopsy of the axillary lymph node, the maximum diameter of which was 3&#x2009;cm. On the basis of clinical presentation and histological findings, the diagnosis of angioimmunoblastic T-cell lymphoma stage IVB was made according to the criteria of WHO classification [<xref ref-type="bibr" rid="B1">1</xref>]. The patient received a combination chemotherapy with pegylated liposomal doxorubicin (30&#x2009;mg/m<sup>2</sup>, day 1), cytarabine (2&#x2009;g/m<sup>2</sup>&#x2009;day 2&#x2013;3) and dexamethasone (40&#x2009;mg&#x2009;day 1&#x2013;4) every 21&#x2009;days. After two cycles, the patient presented a marked improvement of the systemic symptoms and no superficial lymphadenopathies were observed. After 3&#x2009;months a re-stage whole body computed tomography (CT)-scan was performed which showed the disappearance of all previous pathologic findings, but evidenced a lesion of 45&#x2009;mm in the lower pole of the left kidney (Figure <xref ref-type="fig" rid="F1">1</xref>). Such finding was later confirmed by an ultrasound scan, that showed, at the color Doppler exam, a vascular pattern consistent with renal cell carcinoma. The patient was readmitted to the Hospital in order to perform a nephrectomy. The final diagnosis was renal infarction due to PAN, according to Carlson [<xref ref-type="bibr" rid="B18">18</xref>]. The patient had negative rheumatoid factor, HLA-B27, streptolysin O, anti-nuclear, anti-cardiolipin, anti-DNA, anti-smith, anti-RNP, anti-SSA, anti-SSB, anti-neutrophil cytoplasmic and anti-lupus anticoagulant antibodies. Serologies and PCR for both HBV and HCV were negative. The histological diagnosis of PAN was also confirmed by clinicians according to American College of Rheumatology (ACR) criteria [<xref ref-type="bibr" rid="B19">19</xref>]. After six days, the patient was discharged from hospital without complications. He completed the chemotherapy induction program (4 cycles) and underwent consolidation with high-dose chemotherapy and autologous stem cells transplantation. He is well five years after surgery. </p>
        <table-wrap position="float" id="T1">
          <label>Table 1</label>
          <caption>
            <p>Summary of laboratory data</p>
          </caption>
          <table frame="hsides" rules="groups" border="1">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="left">&#xA0;</th>
                <th align="left">
                  <bold>Our values</bold>
                </th>
                <th align="left">
                  <bold>Normal range</bold>
                </th>
              </tr>
            </thead>
            <tbody valign="top">
              <tr>
                <td align="left" valign="bottom">Hb<hr/></td>
                <td align="left" valign="bottom">12,2&#x2009;g/dl<hr/></td>
                <td align="left" valign="bottom">14-18&#x2009;g/dl<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">RBC<hr/></td>
                <td align="left" valign="bottom">5,3&#x2009;&#xD7;&#x2009;10<sup>6</sup>/mm<sup>3</sup><hr/></td>
                <td align="left" valign="bottom">4,5-6&#x2009;&#xD7;&#x2009;10<sup>6</sup>/mm<sup>3</sup><hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">WBC<hr/></td>
                <td align="left" valign="bottom">6,6&#x2009;&#xD7;&#x2009;10<sup>3</sup>/mm<sup>3</sup><hr/></td>
                <td align="left" valign="bottom">4-8&#x2009;&#xD7;&#x2009;10<sup>3</sup>/mm<sup>3</sup><hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Hematocrit<hr/></td>
                <td align="left" valign="bottom">45%<hr/></td>
                <td align="left" valign="bottom">40-52%<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">MCV<hr/></td>
                <td align="left" valign="bottom">90&#x2009;&#x3BC;m<sup>3</sup><hr/></td>
                <td align="left" valign="bottom">83-93&#x2009;&#x3BC;m<sup>3</sup><hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">MCHC<hr/></td>
                <td align="left" valign="bottom">34&#x2009;g/dl<hr/></td>
                <td align="left" valign="bottom">32-36&#x2009;g/dl<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Platelet count<hr/></td>
                <td align="left" valign="bottom">225&#x2009;&#xD7;&#x2009;10<sup>3</sup>/mm<sup>3</sup><hr/></td>
                <td align="left" valign="bottom">150-350&#x2009;&#xD7;&#x2009;10<sup>3</sup>/mm<sup>3</sup><hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">AST<hr/></td>
                <td align="left" valign="bottom">10 UI/l<hr/></td>
                <td align="left" valign="bottom">0-35 UI/l<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">ALT<hr/></td>
                <td align="left" valign="bottom">10 UI/l<hr/></td>
                <td align="left" valign="bottom">0-35 UI/l<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">LDH<hr/></td>
                <td align="left" valign="bottom">552 U/l<hr/></td>
                <td align="left" valign="bottom">120-240 U/l<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Total protein<hr/></td>
                <td align="left" valign="bottom">8,6&#x2009;g/dl<hr/></td>
                <td align="left" valign="bottom">6,5-8,0&#x2009;g/dl<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Albumin<hr/></td>
                <td align="left" valign="bottom">42,3&#x2009;g/l<hr/></td>
                <td align="left" valign="bottom">35,2-50,4&#x2009;g/l<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">&#x3B2;<sub>2</sub>-microglobulin<hr/></td>
                <td align="left" valign="bottom">5.2&#x2009;mg/dL<hr/></td>
                <td align="left" valign="bottom">0,1-0,2&#x2009;mg/dL<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Blood urea nitrogen<hr/></td>
                <td align="left" valign="bottom">32&#x2009;mg/dl<hr/></td>
                <td align="left" valign="bottom">10-50&#x2009;mg/dl<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Creatinine<hr/></td>
                <td align="left" valign="bottom">0,9&#x2009;mg/dl<hr/></td>
                <td align="left" valign="bottom">0-1,3&#x2009;mg/dl<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Blood glucose<hr/></td>
                <td align="left" valign="bottom">96&#x2009;mg/dl<hr/></td>
                <td align="left" valign="bottom">70-110&#x2009;mg/dl<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">C-reactive protein<hr/></td>
                <td align="left" valign="bottom">35&#x2009;mg/l<hr/></td>
                <td align="left" valign="bottom">0-5&#x2009;mg/l<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">ACE<hr/></td>
                <td align="left" valign="bottom">15 U/l<hr/></td>
                <td align="left" valign="bottom">&lt; 40 U/l<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">IgA<hr/></td>
                <td align="left" valign="bottom">1150&#x2009;mg/dl<hr/></td>
                <td align="left" valign="bottom">90-450&#x2009;mg/dl<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">IgG<hr/></td>
                <td align="left" valign="bottom">2245&#x2009;mg/dl<hr/></td>
                <td align="left" valign="bottom">80-1800&#x2009;mg/dl<hr/></td>
              </tr>
              <tr>
                <td align="left">IgM</td>
                <td align="left">135&#x2009;mg/dl</td>
                <td align="left">60-250&#x2009;mg/dl</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic>Hb</italic> Haemoglobin, <italic>RBC</italic> red blood cells count, <italic>WBC</italic> white blood cells count, <italic>MCV</italic> mean corpuscular volume, <italic>MCHC</italic> mean cell haemoglobin concentration, <italic>AST</italic> serum aspartate aminotransferase, <italic>ALT</italic> alanine aminotransferase, <italic>LDH</italic> lactate dehydrogenase, <italic>ACE</italic> angiotensin converting enzyme.</p>
          </table-wrap-foot>
        </table-wrap>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>TC scan findings.</bold> A lesion of 45&#x2009;mm in the upper pole of the left kidney is shown.</p>
          </caption>
          <graphic xlink:href="1746-1596-7-50-1"/>
        </fig>
      </sec>
      <sec>
        <title>Pathologic findings</title>
        <p>Serial sections of both axillary lymph node and left kidney were performed, routinely processed, stained with haematoxylin and eosin and examined by light microscopy. Histologically, the lymph node architecture was partially effaced by polymorphic cellular infiltration, burnt-out follicles (Figure <xref ref-type="fig" rid="F2">2</xref>A) and proliferation of numerous arborizing high-endothelial venules (Figure <xref ref-type="fig" rid="F2">2</xref>B). An expansion of paracortex was observed, which was diffusely infiltrated by a polymorphous population of small to medium-sized lymphocytes, with distinct cell membranes, clear to pale cytoplasm, and mild irregular nuclei (Figure <xref ref-type="fig" rid="F2">2</xref>C). The neoplastic population was admixed with small reactive lymphocytes, eosinophils, plasma cells, histiocytes and numerous follicular dendritic cells. Few large immunoblast-like lymphoid cells with large distinct nuclei and clear cytoplasm were observed intermingled with lymphocytes. In addition, scattered Reed-Sternberg (RS)-like cells with irregular multilobated nuclei and large eosinophilic nucleoli were present in the node. Immunohistochemically, the neoplastic T-cells were positive for CD45Ro, CD3, CD10, LANA-1 and LMP and expressed mostly the CD4 antigen (Figure <xref ref-type="fig" rid="F2">2</xref>D), although numerous reactive CD8 positive T-cells were present. CD20, CD79a, PAX-5, CD56, MUM-1 and CD30 were negative. The large immunoblast-like cells and the scattered RS-like cells showed immunoreactivity to CD20, CD79a and CD30. The proliferation of follicular dendritic cells highlighted by CD21 and CD23 was prominent throughout the node, and entrapped high-endothelial venules. By means of in situ hybridization RNAs (EBERs), EBER-positive signals were observed in scattered large B immunoblasts and RS-like cells (Figure <xref ref-type="fig" rid="F2">2</xref>D, inset). Molecular studies showed monoclonal rearrangement of T-cell receptor genes and polyclonal rearrangement of immunoglobulin heavy chain (IgH) receptor. Macroscopic examination of the left kidney specimen showed a large pale area at the lower pole, approximately 4&#x2009;cm in maximum diameter with a triangular morphology, centered on the renal cortex and consistent with an infarcted area (Figure <xref ref-type="fig" rid="F3">3</xref>A). Coagulative necrosis of renal parenchyma (Figure <xref ref-type="fig" rid="F3">3</xref>B) and multiple segmentary inflammatory lesions of small and middle renal arteries were observed on histological examination. Masson and Giemsa stains showed rupture of internal elastic lamina with aneurysmal collapse of the arterial wall (Figure <xref ref-type="fig" rid="F3">3</xref>C). Some vascular lumina were obliterated by fibrous stroma and sometimes recanalized by thin vascular channels (Figure <xref ref-type="fig" rid="F3">3</xref>D). There was no infiltration by neoplastic T-cells.</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>Axillary lymph node morphology.</bold> Effacement of lymph node architecture with burnt-out follicles (<bold>A</bold>) and marked vascular proliferation (<bold>B</bold>) was observed. The neoplastic cells show clear-to-pale cytoplasm, distinct cell membrane and minimal atypia (<bold>C</bold>); they mainly express CD4 (<bold>D</bold>). EBV-positive B cells are present (inset, <bold>D</bold>). [<bold>A</bold>-<bold>C:</bold> Haematoxylin&#x2013;Eosin (H&amp;E); Original Magnification (O.M.): 40x; <bold>D:</bold> CD4 stain, O.M.: 40x; <bold>D</bold>, inset: EBER in situ hybridization, O.M.: 40x.</p>
          </caption>
          <graphic xlink:href="1746-1596-7-50-2"/>
        </fig>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <p><bold>Renal infarction.</bold> Gross morphology shows a large pale lesion of the lower pole (<bold>A</bold>). Histological examination shows coagulative necrosis of renal parenchyma (<bold>B</bold>), aneurysmal distension of the arterial wall (<bold>C</bold>) and rupture of the internal elastic lamina (<bold>C</bold>, inset, arrow). Some vascular lumina are obliterated by fibrous stroma and recanalized by thin vascular channels (<bold>D</bold>). (<bold>B</bold>-<bold>D:</bold> Masson stain; O.M.: 40x; 20x; 40x).</p>
          </caption>
          <graphic xlink:href="1746-1596-7-50-3"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>AITL is a disease of the middle-aged and elderly people but it rarely occurs in the fourth decade, as it has happened in our patient [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. No standard of care has been established and the prognosis is poor, with a median survival of less than three years [<xref ref-type="bibr" rid="B1">1</xref>]. Responder patients seem to benefit from high dose chemotherapy and autologous stem cell transplantation. AITL was previously considered an atypical reactive process, named angioimmunoblastic lymphadenopathy [<xref ref-type="bibr" rid="B22">22</xref>]; currently, overwhelming evidence deriving from molecular and cytogenetic studies suggests that AITL rises <italic>de novo</italic> as a peripheral T-cell lymphoma [<xref ref-type="bibr" rid="B1">1</xref>]. The nearly constant association with EBV has suggested a possible role for the virus in the etiology, possibly through an antigen-driven process. However, the neoplastic T cells are EBV negative. They express most pan T-cell antigens such as CD3, CD2 and CD5 and, in vast majority of the cases, CD4, although numerous reactive CD8 positive T-cells are often present. In 60-100% of the cases, the tumour cells express CD10, CXCL13 and PD-1. In our case, not only histological examination of lymph node demonstrated morphological features of AITL, but also the presence of T-cell lineage with aberrant CD4 and CD10 expression strongly supported the diagnosis [<xref ref-type="bibr" rid="B22">22</xref>]. Moreover, TCR genes showed clonal rearrangement. Immunoblast-like cells and RS-like cells showed polyclonal IgH rearrangement, thus a concomitant large B cell lymphoma (a well-known complication in AITL) was excluded.</p>
      <p>A review of the literature has demonstrated that a wide spectrum of renal lesions (not only direct infiltration by neoplastic cells) in glomeruli, tubule-interstitium and vessels can develop in patients with AITL and angioimmunoblastic lymphadenopathy [<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B26">26</xref>]. Clinico-pathological features of the patients are listed in Table <xref ref-type="table" rid="T2">2</xref>. To the best of our knowledge, only one case of AITL associated with PAN [<xref ref-type="bibr" rid="B17">17</xref>], has been previously described. It concerned an elderly (71&#x2009;years) man, who developed an intraperitoneal hemorrhage two months after the diagnosis of AITL. PAN is an autoimmune necrotizing systemic vasculitis that preferentially involves small and medium-sized arteries, with signs and symptoms resulting from infarction and scarring of the affected organ. It often starts with non specific symptoms and laboratory features [<xref ref-type="bibr" rid="B27">27</xref>]. Any age group may be affected, but it is commonly seen in people between the ages of 40 and 60, as in our case. The most frequent visceral manifestations involve kidney (93.4%), heart (72%), and gastrointestinal tract (57.4%) [<xref ref-type="bibr" rid="B28">28</xref>]; moreover, several reports indicate that the disease may affect also testis and prostate [<xref ref-type="bibr" rid="B29">29</xref>]. Currently, the most widely used vasculitis classification system is that of the ACR which is based predominantly on clinical findings. Histological diagnosis of vasculitis is performed according to the Chapel Hill Consensus Conference criteria [<xref ref-type="bibr" rid="B30">30</xref>] and to the more recent scheme suggested by Carlson [<xref ref-type="bibr" rid="B18">18</xref>]. The possible mechanism that may explain the relation between AITL and PAN is represented by the induction of an autoimmune phenomenon by the lymphoma. It is well known that AITL cells produce cytokines such as interleukin 6 [<xref ref-type="bibr" rid="B31">31</xref>] and TNF-&#x3B1; [<xref ref-type="bibr" rid="B16">16</xref>], stimulating polyclonal B-cells and plasma cells to secrete antibodies forming circulating immune complexes (CIC). CIC complete the complement cascade, releasing vasoactive substances and chemotactic factors that cause accumulations of inflammatory cells and release of lysosomal enzymes by neutrophils, leading to injury of vessels walls and thrombosis [<xref ref-type="bibr" rid="B17">17</xref>]. In the patient here presented, only serum IgG value and C-reactive protein were elevated whereas platelet count and CIC were normal. Throughout the course of the disease, platelet count decrease and CIC increment was documented. The main diagnostic difficulty was represented by the absence of signs and symptoms of vasculitis; moreover, echo-color-doppler and CT scan findings led to a misdiagnosis of renal carcinoma. Only histological examination of the kidney which showed necrosis of parenchyma and multiple segmentary vasculitis involving small and middle renal arteries allowed the correct diagnosis of PAN which was later confirmed by clinicians. </p>
      <table-wrap position="float" id="T2">
        <label>Table 2</label>
        <caption>
          <p>Clinicopathological features of patients with AITL developing renal involvement</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">
                <bold>Author</bold>
              </th>
              <th align="left">
                <bold>Sex</bold>
              </th>
              <th align="left">
                <bold>Age</bold>
              </th>
              <th align="left">
                <bold>Type of renal lesion</bold>
              </th>
              <th align="left">
                <bold>Interval (months)</bold>
              </th>
              <th align="left">
                <bold>Treatment</bold>
              </th>
              <th align="left">
                <bold>Clinical outcome</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">Wood and Harkins [<xref ref-type="bibr" rid="B13">13</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">76<hr/></td>
              <td align="left" valign="bottom">Diffuse proliferative glomerulonephritis<hr/></td>
              <td align="left" valign="bottom">0<hr/></td>
              <td align="left" valign="bottom">Corticosteroid, cyclophosphamide<hr/></td>
              <td align="left" valign="bottom">Dead for lymphoma<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Wood and Harkins [<xref ref-type="bibr" rid="B13">13</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">79<hr/></td>
              <td align="left" valign="bottom">Minimal change disease<hr/></td>
              <td align="left" valign="bottom">0<hr/></td>
              <td align="left" valign="bottom">Dialysis<hr/></td>
              <td align="left" valign="bottom">Dead for renal failure<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Bhat et al [<xref ref-type="bibr" rid="B8">8</xref>]<hr/></td>
              <td align="left" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">77<hr/></td>
              <td align="left" valign="bottom">Acute renal failure with Bence-Jones proteinuria<hr/></td>
              <td align="left" valign="bottom">4<hr/></td>
              <td align="left" valign="bottom">None<hr/></td>
              <td align="left" valign="bottom">Dead for sepsis<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Platzer et al [<xref ref-type="bibr" rid="B11">11</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">64<hr/></td>
              <td align="left" valign="bottom">Renal failure<hr/></td>
              <td align="left" valign="bottom">0<hr/></td>
              <td align="left" valign="bottom">Prednisolone<hr/></td>
              <td align="left" valign="bottom">CR<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Bello et al [<xref ref-type="bibr" rid="B15">15</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">61<hr/></td>
              <td align="left" valign="bottom">Fanconi syndrome<hr/></td>
              <td align="left" valign="bottom">0<hr/></td>
              <td align="left" valign="bottom">Hydrocortisone<hr/></td>
              <td align="left" valign="bottom">CR<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Bignon et al [<xref ref-type="bibr" rid="B23">23</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">70<hr/></td>
              <td align="left" valign="bottom">Dysproteinaemia<hr/></td>
              <td align="left" valign="bottom">0<hr/></td>
              <td align="left" valign="bottom">n.a.<hr/></td>
              <td align="left" valign="bottom">n.a.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Yamazaki et al [<xref ref-type="bibr" rid="B26">26</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">72<hr/></td>
              <td align="left" valign="bottom">Endocapillary proliferative glomerulonephritis<hr/></td>
              <td align="left" valign="bottom">0<hr/></td>
              <td align="left" valign="bottom">Vincristine, prednisolone<hr/></td>
              <td align="left" valign="bottom">Dead for alimentary tract bleeding<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Nakamoto et al [<xref ref-type="bibr" rid="B10">10</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">40<hr/></td>
              <td align="left" valign="bottom">Acute interstitial nephritis<hr/></td>
              <td align="left" valign="bottom">16<hr/></td>
              <td align="left" valign="bottom">Prednisolone, cyclophosphamide<hr/></td>
              <td align="left" valign="bottom">At 60-month follow-up, no signs of relapse<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Duwaji et al [<xref ref-type="bibr" rid="B28">28</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">71<hr/></td>
              <td align="left" valign="bottom">Proliferative glomerulonephritis<hr/></td>
              <td align="left" valign="bottom">2<hr/></td>
              <td align="left" valign="bottom">CHOP regimen<hr/></td>
              <td align="left" valign="bottom">Dead for sepsis<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Lim et al [<xref ref-type="bibr" rid="B33">33</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">33<hr/></td>
              <td align="left" valign="bottom">Amyloidosis<hr/></td>
              <td align="left" valign="bottom">12<hr/></td>
              <td align="left" valign="bottom">CHOP regimen<hr/></td>
              <td align="left" valign="bottom">At 12-month follow-up, no signs of relapse<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Hamidou et al [<xref ref-type="bibr" rid="B12">12</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">56<hr/></td>
              <td align="left" valign="bottom">Vasculitis<hr/></td>
              <td align="left" valign="bottom">0<hr/></td>
              <td align="left" valign="bottom">CHOP regimen<hr/></td>
              <td align="left" valign="bottom">Dead for renal failure<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">De Samblanx et al [<xref ref-type="bibr" rid="B2">2</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">67<hr/></td>
              <td align="left" valign="bottom">Proliferative glomerulonephritis<hr/></td>
              <td align="left" valign="bottom">0<hr/></td>
              <td align="left" valign="bottom">CHOP regimen<hr/></td>
              <td align="left" valign="bottom">At 12-month follow-up, no signs of relapse<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Goto et al [<xref ref-type="bibr" rid="B9">9</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">73<hr/></td>
              <td align="left" valign="bottom">Direct invasion by lymphoma<hr/></td>
              <td align="left" valign="bottom">0<hr/></td>
              <td align="left" valign="bottom">CHOP regimen<hr/></td>
              <td align="left" valign="bottom">At 20-month follow-up, no signs of relapse<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Miura et al [<xref ref-type="bibr" rid="B7">7</xref>]<hr/></td>
              <td align="left" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">70<hr/></td>
              <td align="left" valign="bottom">IgM-&#x3BB; glomerular thrombi<hr/></td>
              <td align="left" valign="bottom">2<hr/></td>
              <td align="left" valign="bottom">CHOP regimen<hr/></td>
              <td align="left" valign="bottom">At 3-month follow-up, no signs of relapse<hr/></td>
            </tr>
            <tr>
              <td align="left">Tagashi et al [<xref ref-type="bibr" rid="B16">16</xref>]</td>
              <td align="left">M</td>
              <td align="left">21</td>
              <td align="left">Nephrotic syndrome</td>
              <td align="left">0</td>
              <td align="left">CHOP regimen</td>
              <td align="left">At 36-month follow-up, no signs of relapse</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p><italic>CR</italic> complete remission; <italic>n.a.</italic> not available, <italic>CHOP</italic> Cyclophosphamide, doxorubicin, vincristine, prednisolone.</p>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>A careful evaluation is needed in the management of AITL patients which may exhibit immunodeficiency and autoimmunity secondary to the neoplastic process [<xref ref-type="bibr" rid="B32">32</xref>]. Herein we report the first case of PAN presenting at onset with renal involvement, sequential to AITL, in a 40&#x2009;year-old man. PAN has rarely been reported in association with AITL but, although infrequent, clinicians should keep in mind the possibility of an autoimmune disorder involving kidney, in case signs of renal failure develop. Renal biopsy and angiography are necessary in order to avoid delay of treatment and organ damage.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case Report and any all accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>AITL, Angioimmunoblastic T-cell lymphoma; CT, Computed tomography; PAN, Polyarteritis nodosa; WHO, World Health Organization; CIC, Circulating immune complexes; Ig, Immunoglobulins; ACE, Angiotensin converting enzyme; ACR, American College of Rheumatology; RS, Reed-Sternberg; EBER, EBV-encoded RNA; EBV, Epstein-Barr virus; AILD, Angioimmunoblastic lymphadenopathy with dysproteinemia.</p>
    </sec>
    <sec>
      <title>Competing interest</title>
      <p>The Authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>MRA wrote the paper; BJR performed analysis of the histological sections; AG and MO carried out the immunoassays; AF and MC made contributions to acquisition of clinical data; SL contributed his expertise in the field and fruitful discussion; SAT coordinated the work and gave final approval of the version to be published. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="book">
          <name>
            <surname>Dogan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gaulard</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Jaffe</surname>
            <given-names>ES</given-names>
          </name>
          <name>
            <surname>Ralfkiaer</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Muller-Hermelink</surname>
            <given-names>HK</given-names>
          </name>
          <person-group person-group-type="editor">Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW</person-group>
          <article-title>Angioimmunoblastic T-cell lymphoma</article-title>
          <source>WHO Classification of tumours of haematopoietic and lymphoid tissue</source>
          <year>2008</year>
          <edition>4</edition>
          <publisher-name>Lyon: IARC</publisher-name>
          <fpage>309</fpage>
          <lpage>311</lpage>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>De Samblanx</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Verhoef</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zach&#xE8;e</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Vandenberghe</surname>
            <given-names>P</given-names>
          </name>
          <article-title>A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis</article-title>
          <source>Ann Hematol</source>
          <year>2004</year>
          <volume>83</volume>
          <fpage>455</fpage>
          <lpage>459</lpage>
          <pub-id pub-id-type="doi">10.1007/s00277-003-0828-5</pub-id>
          <pub-id pub-id-type="pmid">15034757</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Watanabe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shibaki</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hayasaka</surname>
            <given-names>T</given-names>
          </name>
          <article-title>A case of immunoblastic lymphadenopathy with immune-complex deposition of kidney biopsy specimen</article-title>
          <source>Clin Immunol</source>
          <year>1978</year>
          <volume>10</volume>
          <fpage>967</fpage>
          <lpage>976</lpage>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Staszewski</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mishriki</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Minimal change disease as the etiology of the nephrotic syndrome in a patient with angioimmunoblastic lymphadenopathy</article-title>
          <source>Med Pediatr Oncol</source>
          <year>1988</year>
          <volume>16</volume>
          <fpage>206</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="doi">10.1002/mpo.2950160311</pub-id>
          <pub-id pub-id-type="pmid">3380062</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yoshie</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Oguchi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Furukawa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Satoh</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Iwashita</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Saitoh</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Furuta</surname>
            <given-names>S</given-names>
          </name>
          <article-title>A case of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) associated with nephrotic syndrome which remitted after double filtration plasma pheresis (DFPP) therapy</article-title>
          <source>Nihon Naika Gakkai Zasshi</source>
          <year>1988</year>
          <volume>77</volume>
          <fpage>1440</fpage>
          <lpage>1445</lpage>
          <pub-id pub-id-type="doi">10.2169/naika.77.1440</pub-id>
          <pub-id pub-id-type="pmid">3246561</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dogan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Attygalle</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Kyriakou</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Angioimmunoblastic T-cell lymphoma</article-title>
          <source>Br J Haematol</source>
          <year>2003</year>
          <volume>121</volume>
          <fpage>681</fpage>
          <lpage>691</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2141.2003.04335.x</pub-id>
          <pub-id pub-id-type="pmid">12780782</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Miura</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Yoshino</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kitagawa</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Yamada</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ohtani</surname>
            <given-names>KH</given-names>
          </name>
          <name>
            <surname>Imai</surname>
            <given-names>JH</given-names>
          </name>
          <article-title>Acute renal failure due to IgM-lambda glomerular thrombi and MPGN-like lesions in a patient with angioimmunoblastic T-cell lymphoma</article-title>
          <source>Am J Kidney Dis</source>
          <year>2006</year>
          <volume>48</volume>
          <fpage>3</fpage>
          <lpage>9</lpage>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bhat</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Kerpen</surname>
            <given-names>HO</given-names>
          </name>
          <name>
            <surname>Murthy</surname>
            <given-names>PS</given-names>
          </name>
          <name>
            <surname>Horowitz</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Valderrama</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Angioimmunoblastic lymphadenopathy, Bence Jones proteinuria, and acute renal failure</article-title>
          <source>Arch Intern Med</source>
          <year>1981</year>
          <volume>141</volume>
          <fpage>1373</fpage>
          <lpage>1374</lpage>
          <pub-id pub-id-type="doi">10.1001/archinte.1981.00340100129028</pub-id>
          <pub-id pub-id-type="pmid">7271411</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Goto</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Takada</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Notoya</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mukai</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Angioimmunoblastic T-cell lymphoma with renal involvement; a case report of direct bilateral kidney invasion by lymphoma cells</article-title>
          <source>Ann Hematol</source>
          <year>2004</year>
          <volume>83</volume>
          <fpage>731</fpage>
          <lpage>732</lpage>
          <pub-id pub-id-type="doi">10.1007/s00277-004-0929-9</pub-id>
          <pub-id pub-id-type="pmid">15309529</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nakamoto</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hashimoto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Chubachi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Miura</surname>
            <given-names>AB</given-names>
          </name>
          <name>
            <surname>Watanuki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Konno</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Acute interstitial nephritis with symmetric enlargement of the lacrimal and salivary glands and systemic lymphadenopathy</article-title>
          <source>Am J Nephrol</source>
          <year>1993</year>
          <volume>13</volume>
          <fpage>73</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="doi">10.1159/000168593</pub-id>
          <pub-id pub-id-type="pmid">8322845</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Platzer</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>von Roemeling</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kaduk</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Meinl</surname>
            <given-names>U</given-names>
          </name>
          <article-title>Disease-specific renal failure in angioimmunoblastic lymphadenopathy&#x2014;remission by high dose prednisolone. A case report</article-title>
          <source>Klin Wochenschr</source>
          <year>1981</year>
          <volume>59</volume>
          <fpage>509</fpage>
          <lpage>516</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01696213</pub-id>
          <pub-id pub-id-type="pmid">7241951</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hamidou</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>El Kouri</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Audrain</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Grolleau</surname>
            <given-names>JY</given-names>
          </name>
          <article-title>Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia</article-title>
          <source>Ann Rheum Dis</source>
          <year>2001</year>
          <volume>60</volume>
          <fpage>293</fpage>
          <lpage>295</lpage>
          <pub-id pub-id-type="doi">10.1136/ard.60.3.293</pub-id>
          <pub-id pub-id-type="pmid">11171697</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wood</surname>
            <given-names>WG</given-names>
          </name>
          <name>
            <surname>Harkins</surname>
            <given-names>MM</given-names>
          </name>
          <article-title>Nephropathy in angioimmunoblastic lymphadenopathy</article-title>
          <source>Am J Clin Pathol</source>
          <year>1979</year>
          <volume>71</volume>
          <fpage>58</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">420173</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>S&#xF8;gaard</surname>
            <given-names>PE</given-names>
          </name>
          <name>
            <surname>Molin</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Nephrocalcinosis in angioimmunoblastic lymphadenopathy. A case report</article-title>
          <source>Acta Med Scand</source>
          <year>1982</year>
          <volume>211</volume>
          <fpage>319</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="pmid">7102371</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bello</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Paya</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ruilope</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Jimenez</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Rodicio</surname>
            <given-names>JL</given-names>
          </name>
          <article-title>Angioimmunoblastic lymphadenopathy and transient Fanconi syndrome</article-title>
          <source>Nephron</source>
          <year>1985</year>
          <volume>39</volume>
          <fpage>275</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="doi">10.1159/000183385</pub-id>
          <pub-id pub-id-type="pmid">3974787</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Togashi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wakui</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kodama</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kameoka</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Komatsuda</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nimura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ichinohasama</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sawada</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Angioimmunoblastic T-cell lymphoma and membranous nephropathy: a still unreported association</article-title>
          <source>Clin Exp Nephrol</source>
          <year>2010</year>
          <volume>14</volume>
          <fpage>288</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="doi">10.1007/s10157-010-0266-3</pub-id>
          <pub-id pub-id-type="pmid">20177729</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nakashima</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Okada</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Takada</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kobayashi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hama</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Successful coil embolization of a ruptured hepatic aneurysm in a patient with polyarteritis nodosa accompanied by angioimmunoblastic T cell lymphoma</article-title>
          <source>Clin Rheumatol</source>
          <year>2007</year>
          <volume>26</volume>
          <fpage>1362</fpage>
          <lpage>1364</lpage>
          <pub-id pub-id-type="doi">10.1007/s10067-006-0383-2</pub-id>
          <pub-id pub-id-type="pmid">17106619</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Carlson</surname>
            <given-names>JA</given-names>
          </name>
          <article-title>The histological assessment of cutaneous vasculitis</article-title>
          <source>Histopathology</source>
          <year>2010</year>
          <volume>56</volume>
          <fpage>3</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2559.2009.03443.x</pub-id>
          <pub-id pub-id-type="pmid">20055902</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lightfoot</surname>
            <given-names>RW</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>Michel</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Bloch</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Hunder</surname>
            <given-names>GG</given-names>
          </name>
          <name>
            <surname>Zvaifler</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>McShane</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Arend</surname>
            <given-names>WP</given-names>
          </name>
          <name>
            <surname>Calabrese</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Leavitt</surname>
            <given-names>RY</given-names>
          </name>
          <name>
            <surname>Lie</surname>
            <given-names>JT</given-names>
          </name>
          <article-title>The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa</article-title>
          <source>Arthritis Rheum</source>
          <year>1990</year>
          <volume>33</volume>
          <fpage>1088</fpage>
          <lpage>1093</lpage>
          <pub-id pub-id-type="pmid">1975174</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Frizzera</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Moran</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Rappaport</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Angio-immunoblastic lymphadenopathy with dysproteinaemia</article-title>
          <source>Lancet</source>
          <year>1974</year>
          <volume>1</volume>
          <fpage>1070</fpage>
          <lpage>1073</lpage>
          <pub-id pub-id-type="pmid">4135245</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lukes</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Tindle</surname>
            <given-names>BH</given-names>
          </name>
          <article-title>Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin&#x2019;s disease</article-title>
          <source>New Engl J Med</source>
          <year>1975</year>
          <volume>292</volume>
          <fpage>1</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM197501022920101</pub-id>
          <pub-id pub-id-type="pmid">1078547</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yang</surname>
            <given-names>QX</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>XJ</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>XY</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Z</given-names>
          </name>
          <article-title>Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature</article-title>
          <source>Diagn Pathol</source>
          <year>2012</year>
          <volume>7</volume>
          <issue>1</issue>
          <fpage>7</fpage>
          <comment>[Epub ahead of print].</comment>
          <pub-id pub-id-type="doi">10.1186/1746-1596-7-7</pub-id>
          <pub-id pub-id-type="pmid">22260632</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bignon</surname>
            <given-names>YJ</given-names>
          </name>
          <name>
            <surname>Janin-Mercier</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dubost</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Ristori</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Fonck</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Alphonse</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Sauvezie</surname>
            <given-names>BJ</given-names>
          </name>
          <article-title>Angioimmunoblastic lymphadenopathy with dysproteinaemia (AILD) and sicca syndrome</article-title>
          <source>Ann Rheum Dis</source>
          <year>1986</year>
          <volume>45</volume>
          <fpage>519</fpage>
          <lpage>522</lpage>
          <pub-id pub-id-type="doi">10.1136/ard.45.6.519</pub-id>
          <pub-id pub-id-type="pmid">3729577</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Klimenko</surname>
            <given-names>OV</given-names>
          </name>
          <name>
            <surname>Semenkova</surname>
            <given-names>EN</given-names>
          </name>
          <name>
            <surname>Krivosheev</surname>
            <given-names>OG</given-names>
          </name>
          <article-title>The peculiarities of renal lesion in nodular polyarteritis</article-title>
          <source>Klin Med (Mosk)</source>
          <year>2006</year>
          <volume>84</volume>
          <fpage>44</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">16613006</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lachenal</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ghesqui&#xE8;res</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Biron</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hot</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Callet-Bauchu</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Chassagne</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Coiffier</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Durieu Rousset</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Salles</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients</article-title>
          <source>Medicine (Baltimore)</source>
          <year>2007</year>
          <volume>86</volume>
          <fpage>282</fpage>
          <lpage>292</lpage>
          <pub-id pub-id-type="doi">10.1097/MD.0b013e3181573059</pub-id>
          <pub-id pub-id-type="pmid">17873758</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yamazaki</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Inaba</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Nemoto</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Iizuka</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Fujikawa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Horiguchi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yamada</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Acute renal failure due to endocapillary proliferative glomerulonephritis in a patient with IBL-like T-cell lymphoma</article-title>
          <source>Rinsho Ketsueki</source>
          <year>1991</year>
          <volume>32</volume>
          <fpage>796</fpage>
          <lpage>801</lpage>
          <pub-id pub-id-type="pmid">1920845</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Uehara</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sato</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Iwashiro</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yokota</surname>
            <given-names>S</given-names>
          </name>
          <article-title>PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2</article-title>
          <source>Diagn Pathol</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>23</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-4-23</pub-id>
          <pub-id pub-id-type="pmid">19594951</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Duwaji</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Shemin</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Medeiros</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Esparza</surname>
            <given-names>AR</given-names>
          </name>
          <article-title>Proliferative glomerulonephritis with unusual, organized, cylindrical deposits associated with angioimmunoblastic lymphadenopathylike T-cell lymphoma</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>1995</year>
          <volume>119</volume>
          <fpage>377</fpage>
          <lpage>380</lpage>
          <pub-id pub-id-type="pmid">7726733</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gonz&#xE0;lez-La Riviere</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>de la Torre-Rend&#xF2;n</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Hern&#xE0;ndez-V&#xE0;squez</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Arce-Salinas</surname>
            <given-names>CA</given-names>
          </name>
          <article-title>Polyarteritis nodosa mimicking prostatic cancer</article-title>
          <source>J Rheumatol</source>
          <year>2000</year>
          <volume>27</volume>
          <fpage>2504</fpage>
          <lpage>2506</lpage>
          <pub-id pub-id-type="pmid">11036851</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Jennett</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Falk</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Andrassy</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Nomenclature of systemic vasculitides. Proposal of an international consensus conference</article-title>
          <source>Arthritis Rheum</source>
          <year>1994</year>
          <volume>37</volume>
          <fpage>187</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="doi">10.1002/art.1780370206</pub-id>
          <pub-id pub-id-type="pmid">8129773</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Oka</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nagayama</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yatabe</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Iijima</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mori</surname>
            <given-names>N</given-names>
          </name>
          <article-title>Angioimmunoblastic T-cell lymphoma with autoimmune thrombocytopenia: a report of two cases</article-title>
          <source>Pathol Res Pract</source>
          <year>2010</year>
          <volume>206</volume>
          <fpage>270</fpage>
          <lpage>275</lpage>
          <pub-id pub-id-type="doi">10.1016/j.prp.2009.04.002</pub-id>
          <pub-id pub-id-type="pmid">19442454</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gonzalez-Cuyar</surname>
            <given-names>LF</given-names>
          </name>
          <name>
            <surname>Tavora</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>XF</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Auerbach</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Aguilera</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Burke</surname>
            <given-names>AP</given-names>
          </name>
          <article-title>Angiolymphoid hyperplasia with eosinophilia developing in a patient with history of peripheral T-cell lymphoma: evidence for multicentric T-celllymphoproliferative process</article-title>
          <source>Diagn Pathol</source>
          <year>2008</year>
          <volume>3</volume>
          <fpage>22</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-3-22</pub-id>
          <pub-id pub-id-type="pmid">18510751</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lim</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Ferreira</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Majumdar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wheeler</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Lipkin</surname>
            <given-names>GW</given-names>
          </name>
          <article-title>Renal amyloidosis and angioimmunoblastic lymphadenopathy</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>1998</year>
          <volume>13</volume>
          <fpage>453</fpage>
          <lpage>454</lpage>
          <pub-id pub-id-type="doi">10.1093/ndt/13.2.453</pub-id>
          <pub-id pub-id-type="pmid">9509462</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
